Related Experiment Video
Updated: Apr 18, 2026

Mammary Epithelial Transplant Procedure
Published on: June 10, 2010
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis by glyceollins
Bo Ram Kim1, Ji-Yeon Seo, Mi-Kyung Sung
1School of Food Science and Biotechnology, Kyungpook National University, Daegu, Republic of Korea.
Scope:
Our previous study showed that glyceollins induced phase 2 detoxifying and antioxidant enzymes. As chemical carcinogens can be detoxified by metabolic activity of phase 2 enzymes, subsequently decreasing their tumorigenic potential, we investigated whether 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumorigenesis could be attenuated by treatment with glyceollins in a mouse model.
Methods And Results:
Pretreatment with glyceollins (5 mg/kg body weight) caused a significant reduction in tumor formation and an increase in survival rate. The protective effect of glyceollins against DMBA-induced tumorigenesis was found to be mainly associated with their potential to induce phase 2/antioxidant enzymes that are, in turn, regulated by the nuclear factor E2-related factor 2 signaling pathway, and to a less extent to suppress phase 1 enzymes. As glyceollins increased the number of terminal end buds, a tumor-prone mammary tissue type in mice, it is unlikely that they exert their antitumorigenic action through their estrogenic activity.
Conclusion:
Glyceollins were found to have a protective effect in a chemically induced mammary tumor model.
Insights
Glyceollins show protective effects against 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in mice. This study demonstrates glyceollins
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Glyceollins are known to induce phase 2 detoxifying and antioxidant enzymes.
- Phase 2 enzymes are crucial for metabolizing and detoxifying chemical carcinogens.
- This detoxification process can reduce the carcinogenic potential of harmful substances.
Purpose of the Study:
- To investigate the potential of glyceollins in attenuating 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumorigenesis.
- To evaluate the protective effects of glyceollins in a chemically induced mammary tumor mouse model.
Main Methods:
- Mice were pretreated with glyceollins (5 mg/kg body weight) before exposure to DMBA.
- Tumor formation and survival rates were monitored.
- The study analyzed the mechanisms underlying glyceollins' effects, including the induction of phase 2/antioxidant enzymes and suppression of phase 1 enzymes.
- The role of the nuclear factor E2-related factor 2 (Nrf2) signaling pathway was examined.
- The estrogenic activity of glyceollins was assessed by observing their effect on terminal end buds.
Main Results:
- Glyceollin pretreatment significantly reduced mammary tumor formation in the DMBA-induced mouse model.
- A notable increase in the survival rate of treated mice was observed.
- The primary mechanism involved the induction of phase 2/antioxidant enzymes via the Nrf2 signaling pathway.
- Glyceollins also showed a moderate suppression of phase 1 enzymes.
- Glyceollins did not appear to exert their antitumorigenic action through estrogenic activity, as evidenced by an increase in terminal end buds.
Conclusions:
- Glyceollins demonstrate a significant protective effect in a chemically induced mammary tumor model.
- The findings suggest glyceollins are a promising agent for cancer prevention, particularly in mammary carcinogenesis.
- The mechanism is linked to the modulation of key enzymatic pathways involved in carcinogen metabolism and detoxification.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020